Live Webinar SaaS Valuations in 2026: Public and Private Markets Update Tue, Nov 17 11am ET / 5pm CET Register

Environmental Testing Laboratory Valuation: EV/EBITDA & EV/Revenue

Owners of environmental, water and asbestos testing labs can benchmark their business here against comparable deals and see who is buying.

Marcin Majewski
Published October 14, 2026 · 12 min read · Connect on LinkedIn

Selling an environmental testing laboratory, a water testing lab or an asbestos lab is usually a once-in-a-career event for the owner who built it, and the price agreed is the market’s judgment on everything that went into it: the accreditations, the trained analysts and the clients who send samples every month. That judgment depends on how many credible buyers compete for the lab: 69 different buyers have acquired labs like these since 2015. This page shows the prices paid for environmental testing laboratories, the factors that move a buyer’s offer and the groups that have been acquiring them.

Regulation sets the calendar for much of the work in environmental testing laboratories: water suppliers must test drinking water at set frequencies, discharge permits call for regular wastewater samples, and asbestos has to be identified before buildings are refurbished or demolished. Environmental testing laboratories analyze drinking water, wastewater, groundwater, soil, waste and air for contaminants; asbestos labs identify fibers in building materials and air samples, and many of them also test for lead, mold and radon.

Laboratory groups and private equity-backed platforms have been consolidating the segment, so a well-run lab can draw both kinds of buyer into one sale. We count 255 acquisitions of environmental testing laboratories since 2015, 159 of them since 2021, with 34 in 2024 and 33 in 2025. They include 34 water testing laboratories and 28 asbestos laboratories; most of the rest are environmental analytical labs.

In short, an EBITDA multiple is public for two environmental lab deals, and their median sits above the usual range for testing laboratories, so for EBITDA the table points to all testing laboratories. The eight published revenue multiples have a median of about 1.7x revenue, below the 2.4x for all testing laboratories and a little below the 1.8x for all TIC deals on our pages. For EBITDA, use the median of 10.1x across 24 testing laboratory deals. The median deal size behind those 24 deals is about $60M.

Environmental Testing Laboratory Deal Multiples Compared With the Wider TIC Market

Of the 255 environmental testing laboratory deals since 2015, 17 carry a published deal value. With acquirer announcements and company filings added, 2 deals give an EV/EBITDA multiple and 8 an EV/Revenue multiple, so the segment figures are a guide only.

Environmental testing laboratoriesAll testing laboratoriesAll TIC (our three hubs)
Median EV/EBITDANot shown (2 deals): see All testing laboratories10.1x (24 deals)9.9x (54 deals)
Median EV/Revenue1.7x (8 deals)2.4x (72 deals)1.8x (142 deals)
Median deal size (EV where disclosed, otherwise the disclosed deal value)$23.4M (17 deals)$13.4M (128 deals)$13.4M (282 deals)
Source: Aventis Advisors TIC deal database.

The median deal size in the segment, about $23.4M, leans toward larger labs: most of the 17 published values come from listed testing groups, which report more of their purchases. A smaller lab should expect a multiple below these medians unless several buyers compete for it and it can show a broad accreditation scope and a regulated, repeating sample flow.

We track every environmental testing laboratory acquisition since 2015, 255 deals by 69 different buyers, so we know which buyers fit a lab like yours and what they have paid.

What is your lab worth?

Send us three numbers: revenue, EBITDA and revenue growth rate. Within two working days we show you in confidence how your lab measures up against 255 environmental testing laboratory deals, which buyer groups have acquired labs like yours, and how any offer you hold compares with what they paid where terms are published.

Request your valuation assessment or email the numbers to marcin.majewski@aventis-advisors.com.

What Drives an Environmental Testing Laboratory Valuation

A buyer works through the points below when it examines an environmental, water or asbestos testing laboratory, and the answers move the price up or down. Several depend on records kept over two or three years, which are hard to produce in the months before a sale.

Accreditation and certification scope

A laboratory’s results are worth paying for only when a regulator or client accepts them, so a buyer starts with what the accreditations cover. It reads the ISO/IEC 17025 schedule method by method and matrix by matrix, then the approvals that sit on top of it: state laboratory certification and TNI (NELAP) accreditation in the US, drinking water certification in each state served, MCERTS for the chemical testing of soil in the UK, and accreditation from national bodies such as UKAS, DAkkS, Cofrac or RvA in Europe. For asbestos, lead and mold analysis in the US it looks for NVLAP and AIHA-LAP accreditation. Show this: the current schedule for each site, with the date of the last assessment and any open findings.

Regulated, repeating sample flow

Drinking water, wastewater and pool water are tested at frequencies set by regulators, permits and health authorities, so a water laboratory with utility, municipal and industrial clients receives the same samples month after month. Asbestos analysis follows building work: in the UK the Control of Asbestos Regulations 2012 require asbestos to be identified before refurbishment or demolition, and in France the file a seller must provide for an older building includes an asbestos check. Site investigations for property deals and one-off remediation sampling have to be won again each time. Buyers value scheduled compliance testing above project work, so show three years of revenue split between the two.

Methods and new contaminants

Methods that competitors find hard to add carry a premium. PFAS is the current example: the US EPA set six PFAS limits for drinking water in 2024 and proposed in May 2026 to rescind four of them, keeping the limits for PFOA and PFOS, and the PFAS limits in the EU Drinking Water Directive apply from January 2026. Both call for accredited analysis at very low concentrations on LC-MS/MS instruments. Dioxins, radiochemistry and trace metals are similar cases. Show this: revenue by specialist method for the last three years, with the instruments behind each.

Where the samples come from

Environmental consultants, engineering firms, utilities and public agencies send most samples to environmental labs, and asbestos labs often depend on a group of survey firms. A buyer counts how many clients make up half of revenue, which of them work under framework agreements, and when utility contracts and public tenders come up for renewal. A consultancy or survey firm owned by a competing laboratory group can move its samples after a sale, and buyers look for that exposure.

Capacity, turnaround and logistics

A laboratory’s costs are largely fixed, so margin follows how full the instruments are. Buyers look at samples processed per instrument line, how often reports go out within the agreed turnaround, the age of the main instruments, the laboratory information management system and the couriers and sample collection that feed the lab. Spare capacity is worth most to a buyer that already collects samples in your region and can send its own volume to your lab.

Technical manager, signatories and analysts

Accreditation depends on named people: the technical manager, the approved signatories and analysts qualified for each method, such as BOHS P401 for identifying asbestos in bulk samples in the UK. If the owner is the main signatory, the buyer prices that risk until a second person is approved for the role.

Size and fit with a laboratory network

Larger groups run routine analysis in big central labs and keep regional sites for fast turnaround and sample collection. A buyer asks where your lab would sit in that network. Smaller labs are mostly bought as add-ons, and the price allows for the cost of integration and for client concentration.

How we present these to buyers. A buyer pays for what it can see and check. Part of our work in a sale is to present the business as strongly as the facts allow: we set out the accredited methods, show the regulated sample flow behind the revenue, and document the technical manager and signatories, and we deal with weak points before a buyer finds them and uses them to lower the offer. A valuation assessment is the place to start, a year or two before a sale.

Who Is Buying Environmental Testing Laboratories

We count 255 acquisitions of environmental testing laboratories since January 2015, made by 69 different buyers. Private equity firms and their platforms made 37% of them, below the 42% for all testing laboratories. Their share rose from 27% of the 96 deals in 2015 to 2020 to 43% of the 159 deals since 2021. The targets were in 37 countries: 107 in North America, 100 in continental Europe (19 countries), 17 in Asia-Pacific, 13 in the UK and Ireland, 9 in Latin America, 8 in Australia and New Zealand and 1 in the Middle East and Africa.

Eurofins Scientific, SGS and ALS are listed testing groups that buy across many sectors and use environmental laboratories to add regions and methods. Pace Analytical Services, a private equity-backed US laboratory network, and GBA Group, a private equity-backed German laboratory group, build regional networks, and Pace buys asbestos and water testing labs alongside environmental labs.

BuyerHeadquartersOwnershipEnvironmental testing lab dealsOther TIC dealsTotal TIC deals
Eurofins Scientific logoEurofins ScientificLuxembourgListed67175242
Pace Analytical logoPace Analytical ServicesUSPE-backed23528
SGS logoSGSSwitzerlandListed14103117
ALS logoALSAustraliaListed102636
GBA Group logoGBA GroupGermanyPE-backed102030
Source: Aventis Advisors TIC deal database.

For an owner, the table points to two routes to a sale: a listed testing group adding a region or a method to its network, and a private equity-backed laboratory platform building scale through add-ons. The two weigh the same lab differently and expect different things from the owner after completion; see strategic vs financial buyers.

One buyer’s offer tells you what that buyer would like to pay. Offers from several buyers, made at the same time on the same information, tell you what the business is worth. That is what a sale process does, and it is the work we do for owners: talk to us before you reply to an approach.

Selling an Environmental Testing Laboratory: What a Run Process Changes

An approach usually comes on the buyer’s timetable, on the buyer’s terms and as the only offer on the table, so an owner who answers it alone is negotiating with one party. A competitive sale process changes that in four ways, and running it is what we do for owners.

Several buyers bid at the same time. Private equity firms and their platforms made 43% of the 159 deals since 2021, and 69 different buyers have acquired environmental testing laboratories since 2015. A listed testing group and a private equity-backed laboratory platform value the same lab differently, and offers made in the same week, on the same information, show what the market will pay.

The process sets the terms of engagement. The seller sets the timetable, the information each buyer sees and the date offers are due, so competition between buyers sets the value.

Every term is negotiated while alternatives exist. How samples are counted once a buyer moves routine analysis into its central lab, the cash paid at completion and the terms that keep your technical manager and signatories in place all move most while a second buyer is still in the process.

The business is ready before the first call. The ISO/IEC 17025 schedule and every state or national certification with its change-of-ownership rules, three years of revenue by method, matrix and client, the split between scheduled and project work, the instrument register, turnaround records and the list of signatories. We prepare all of it with you before any buyer is contacted.

Why Laboratory Owners Work With Us

We advise owners on sales with typical enterprise values between $5M and $100M, as partners of the Globalscope network. We also advise serial acquirers, which is how we know the way their offers are built and where they leave room.

Recent transactions:

  • Advice to Apave on its acquisitions of ISOCERT and De Duurzame Adviseurs.
  • Sale of CKSource, the rich-text editor developer, to PSG via Tiugo Technologies, after a global process that drew several letters of intent.
  • Advice to Visma on its acquisition of SaldeoSMART.

“We were impressed with Marcin’s negotiating skills and Aventis’ ability to make things happen.”

Sindre Talleraas Holen, M&A Director, Visma

“Aventis Advisors did the heavy lifting so that our management team could stay focused on our business.”

Wiktor Walc, President, CKSource

Before you reply to a buyer

Send us three numbers: revenue, EBITDA and revenue growth rate. Within two working days we show you in confidence how your lab measures up against 255 environmental testing laboratory deals, which buyer groups have acquired labs like yours, and how any offer you hold compares with what they paid where terms are published.

Request your valuation assessment

Talk to Us

If a laboratory group or platform has written to you about your environmental, water or asbestos lab, call us before you reply, agree a price or sign a letter of intent. We run competitive sale processes for owners: we prepare the business, approach the listed testing groups and private equity-backed platforms most likely to pay for your accreditations, regulated sample volumes, methods and team, bring their offers to a single deadline and negotiate through to completion. Aventis Advisors is a boutique M&A firm advising on transactions with typical enterprise values between $5M and $100M. Write to us at marcin.majewski@aventis-advisors.com. The first conversation is confidential. For more on how we work, see our M&A advisory for TIC companies.

Methodology

The figures cover majority acquisitions of companies whose main business is testing water, soil, air and waste samples in their own laboratories, including drinking, waste and pool water and asbestos, lead, mold and radon testing, worldwide, since January 2015. Laboratories that collect their own samples are counted. Stack testing crews, asbestos surveyors, legionella and water hygiene services, field monitoring firms and environmental consultancies are excluded; food laboratories are covered on our food and agricultural testing laboratory page and oil and fuel analysis on our materials testing laboratory page.

The deals come from the Aventis Advisors TIC deal database, which combines Mergermarket with acquirer announcements and our own research. EV/EBITDA and EV/Revenue use enterprise value (EV), which is equity value plus net debt; EBITDA is earnings before interest, tax, depreciation and amortization. Median deal size uses EV where disclosed, otherwise the disclosed deal value, which is the consideration for the stake acquired; stakes of 51% to 99% count only where an EV is stated. Distressed sales, and multiples outside 1x to 60x EBITDA or 0.05x to 20x revenue, are excluded from the multiples. Most private deals close at undisclosed values, so the deals with a published figure are a small sample. A median from as few as two deals is shown only where it falls inside the interquartile range of the next wider group, such as all testing laboratories; otherwise the page points to that group. Ranges need at least ten deals. EV/EBITDA is shown where the multiple or the EBITDA was published by the buyer, the seller, filings or a reputable data source; EBITDA derived from a stated margin is excluded. Each deal is counted under the buyer’s group at the time of the deal, and private equity buyers are private equity firms and the companies they owned then. All TIC combines the inspection, testing laboratory and certification deals on our pages, 2,841 since 2015.

Marcin Majewski

Founder and Managing Partner

As the founder of Aventis Advisors, Marcin has more than 20 years of experience in M&A and Corporate Finance. He specializes in the Technology sector with a particular focus on Software, IT Services as well as Business Services. During his career, he’s advised dozens of entrepreneurs and investors. Marcin is passionate about working with diverse people and learning the fascinating histories of founders. It’s all about connecting the world of business and finance, the creativity that goes into structuring deals (as each deal is unique), and developing meaningful connections between people worldwide.

Frequently asked questions

Published deals give environmental testing laboratories a median of about 1.7x revenue (8 deals), and with only two disclosing an EBITDA multiple, the EBITDA reference is 10.1x across 24 testing laboratory deals of all kinds. Where your own lab lands depends on its accreditation scope, methods, share of scheduled compliance testing, client mix and team. The way to establish where it lands is to put the business in front of several buyers at once, in a sale process run for you.

Usually below the 10.1x median for testing laboratories, because the 24 deals behind that median had a median deal size of about $60M. The middle half of those deals sold at 8.0x to 12.9x EBITDA. Labs that come closest to the median have a broad accreditation scope, specialist methods, regular compliance samples and more than one approved signatory.

Buyer activity has been high: 159 environmental testing laboratories were acquired since 2021, against 96 in the six years 2015 to 2020, with 34 in 2024 and 33 in 2025. The right moment for your own lab also depends on its recent results: buyers pay more for growing revenue, a steady flow of compliance samples and accreditations in good standing. A valuation assessment against the deals on this page shows where your lab stands today; send us four numbers and we reply within two working days.

Most of what moves the multiple takes a year or more to build: a broad accreditation scope and a regulated, repeating sample flow. Owners who start two years out choose the timing of their sale. A valuation assessment now shows which of those levers matters for your lab.

Yes. An offer from one buyer is priced without competition. We run a competitive sale process for you: we approach the listed testing groups and private equity-backed platforms with a real reason to want your lab, bring their offers to one deadline on the same information, and negotiate the price and terms through to closing, so you choose between the best offers, including the first. Talk to us before you reply to the buyer.

A run process is confidential. Buyers sign a confidentiality agreement before they see the lab’s name or numbers, and staff and customers are told at the point you choose.

Buyers use the same measures, with different weight on each. A water testing lab is judged closely on its drinking water certifications and on contracts with utilities, municipalities and pool operators that send samples on a fixed schedule. An asbestos lab is judged on its accreditation for fiber analysis, its qualified analysts and the survey firms that send it samples. The same buyers acquire all three kinds: Pace Analytical Services, for example, has bought 5 asbestos and 4 water testing labs among its 23 deals in the segment. With eight published revenue multiples in the whole segment, a separate median for each kind of lab would rest on one or two deals.

In a share sale they usually stay in place, because the same company keeps holding them, though accreditation bodies and certifying authorities expect to be told of the new owner and some carry out a new assessment. In an asset sale the buyer’s company normally has to obtain them again, which takes time and can interrupt work that needs a certified lab. In the US, state certification programs set their own rules, and some treat a change of ownership as needing a new application or an on-site assessment.

It can, where the PFAS work is accredited, growing and profitable. Drinking water rules in the US and the EU call for accredited low-level PFAS analysis, including the US limits for PFOA and PFOS that the EPA has proposed to keep, so demand for it rests on regulation. Buyers look at how much revenue PFAS and other specialist methods bring in, how fast it is growing, the instruments behind it and whether the methods are on the accreditation schedule. Three years of revenue by method makes the case.

Contact Us

Tell us about what you want to achieve; we can support you from start to close on your M&A journey.